Laura Bojke

3.7k total citations
93 papers, 2.5k citations indexed

About

Laura Bojke is a scholar working on Economics and Econometrics, General Health Professions and Sociology and Political Science. According to data from OpenAlex, Laura Bojke has authored 93 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Economics and Econometrics, 26 papers in General Health Professions and 12 papers in Sociology and Political Science. Recurrent topics in Laura Bojke's work include Health Systems, Economic Evaluations, Quality of Life (40 papers), Healthcare cost, quality, practices (15 papers) and Spondyloarthritis Studies and Treatments (11 papers). Laura Bojke is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (40 papers), Healthcare cost, quality, practices (15 papers) and Spondyloarthritis Studies and Treatments (11 papers). Laura Bojke collaborates with scholars based in United Kingdom, Spain and Canada. Laura Bojke's co-authors include Karl Claxton, Mark Sculpher, Stephen Palmer, Su Golder, Marta Soares, David Epstein, Linda Sharples, Susan Griffin, Christopher Jackson and Sebastian Hinde and has published in prestigious journals such as Annals of the Rheumatic Diseases, American Journal of Preventive Medicine and Statistics in Medicine.

In The Last Decade

Laura Bojke

90 papers receiving 2.5k citations

Peers

Countries citing papers authored by Laura Bojke

Since Specialization

Citations

This map shows the geographic impact of Laura Bojke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Bojke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Bojke more than expected).

Fields of papers citing papers by Laura Bojke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Bojke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Bojke. The network helps show where Laura Bojke may publish in the future.

Co-authorship network of co-authors of Laura Bojke

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Bojke. A scholar is included among the top collaborators of Laura Bojke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Bojke. Laura Bojke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Systematic Review of the Impact of Changes to Urban Green Spaces on Health and Education Outcomes, and a Critique of Their Applicability to Inform Economic Evaluation 2024 ·International Journal of Environmental Research and Public Health ·(unknown), Laura Bojke, Peter Coventry, Peter J. Murphy, (unknown), Piran C. L. White	2
2	Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model 2024 ·Health Technology Assessment ·Beth Woods, (unknown), Dina Janković, Benjamin Kearns, Alison Scope, Shijie Ren, (unknown), (unknown), Jean Hamilton, Claire Rothery, Laura Bojke, Mark Sculpher, S Harnan	3
3	Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model 2024 ·Health Technology Assessment ·S Harnan, Benjamin Kearns, Alison Scope, (unknown), Dina Janković, Jean Hamilton, (unknown), Harry Hill, (unknown), Shijie Ren, Claire Rothery, Laura Bojke, Mark Sculpher, Beth Woods	0
4	Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis 2024 ·Health Technology Assessment ·Mark Simmonds, Alexis Llewellyn, Ruth Walker, (unknown), Matthew Walton, Robert Hodgson, Laura Bojke, Lesley Stewart, Sofia Dias, (unknown), John G Lawrenson, Tünde Pető, David Steel	6
5	OP0271 INCIDENCE OF PSORIATIC ARTHRITIS AND PREVALENCE OF UNDIAGNOSED CASES IN A UK PRIMARY CARE POPULATION FOLLOWED PROSPECTIVELY FOR 2 YEARS - RESULTS FROM THE TUDOR RANDOMIZED CLINICAL TRIAL 2023 ·Annals of the Rheumatic Diseases ·Neil McHugh, Laura Bojke, Laura C. Coates, Claire Davies, Philip Helliwell, Jon Packham, Michael R. Ransom, Eldon Spackman, William Tillett, Sarah Brown	0
6	Digital interventions in mental health: evidence syntheses and economic modelling 2022 ·Health Technology Assessment ·Lina Gega, Dina Janković, Pedro Saramago, David Marshall, Sarah Dawson, Sally Brabyn, Georgios F. Nikolaidis, Hollie Melton, Rachel Churchill, Laura Bojke	22
7	Taking a local government perspective for economic evaluation of a population-level programme to promote exercise 2021 ·Health Policy ·Paolo Candio, David Meads, Andrew J. Hill, Laura Bojke	4
8	Reference Case Methods for Expert Elicitation in Health Care Decision Making 2021 ·Medical Decision Making ·Laura Bojke, Marta Soares, Karl Claxton, Abigail Colson, (unknown), Christopher Jackson, Dina Janković, Alec Morton, Linda Sharples, Andrea Taylor	27
9	Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study 2021 ·Health Technology Assessment ·Laura Bojke, Marta Soares, Karl Claxton, Abigail Colson, (unknown), Christopher Jackson, Dina Janković, Alec Morton, Linda Sharples, Andrea Taylor	46
10	Cost-effectiveness of a proportionate universal offer of free exercise: Leeds Let’s Get Active 2020 ·Journal of Public Health ·Paolo Candio, David Meads, Andrew J. Hill, Laura Bojke	4
11	Systematic Review and Critique of Methods for Economic Evaluation of Digital Mental Health Interventions 2020 ·Applied Health Economics and Health Policy ·Dina Janković, Laura Bojke, David Marshall, Pedro Saramago, Rachel Churchill, Hollie Melton, Sally Brabyn, Lina Gega	21
12	Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT 2020 ·Health Technology Assessment ·Ruth Gilbert, Michaela Brown, Rita Faria, Caroline Fraser, Chloe Donohue, Naomi Rainford, (unknown), Ajay Sinha, Jon Dorling, J. Gray, Berit Müller‐Pebody, Katie Harron, Tracy Moitt, (unknown), Laura Bojke, Carrol Gamble, Sam Oddie	12
13	Cost-effectiveness of strategies preventing late-onset infection in preterm infants 2019 ·Archives of Disease in Childhood ·(unknown), Rita Faria, Laura Bojke, Chloe Donohue, Caroline Fraser, Katie Harron, Sam Oddie, Ruth Gilbert	7
14	Understanding and addressing the challenges of conducting quantitative evaluation at a local level: a worked example of the available approaches 2019 ·BMJ Open ·Sebastian Hinde, Laura Bojke, Gerry Richardson	1
15	A pharmacoeconomic approach to assessing the costs and benefits of air quality interventions that improve health: a case study 2016 ·BMJ Open ·James Lomas, (unknown), Sally Jones, (unknown), Elizabeth J Bates, Mike Holland, (unknown), (unknown), M.R. Ashmore, David Rojas‐Rueda, Helen Weatherly, Gerry Richardson, Laura Bojke	16
16	Negative pressure wound therapy for severe pressure ulcers: Evidence synthesis and the value of further research 2011 ·Wound Repair and Regeneration ·Marta Soares, Jo C Dumville, Rebecca L Ashby, C Iglesias, Laura Bojke, Una Adderley, Elizabeth McGinnis, Nikki Stubbs, David Torgerson, K Claxton, Nicky Cullum	3
17	The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease – a UK collaborative study. The REFLUX trial 2008 ·Health Technology Assessment ·Adrian Grant, (unknown), Craig Ramsay, Laura Bojke, David Epstein, Mark Sculpher, Susan Macran, Mary Kilonzo, Luke Vale, Jill Francis, (unknown), Z H Krukowski, R C Heading, Mark Thursz, Ian Russell, Marion Campbell	93
18	Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses 2007 ·Health Technology Assessment ·Tim Colbourn, Christian Asseburg, Laura Bojke, Z Philips, Karl Claxton, A. E. Ades, Ruth Gilbert	58
19	Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children 2006 ·Health Technology Assessment ·Penny Whiting, Angela Wood, Laura Bojke, Stephen Palmer, Gerry Richardson, J Cooper, Ian Watt, Julie Glanville, Mark Sculpher, Jos Kleijnen	2
20	Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation 2006 ·Health Technology Assessment ·Caroline Main, Laura Bojke, Susan Griffin, Gill Norman, Marco Barbieri, Lisa Mather, Dan Stark, Stephen Palmer, R.P. Riemsma	142

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact